| Code | 14993 | ||||||||||
| MA number | 48/0216/96-S | ||||||||||
| Product Form: | sol inj 6x500 ml (fľ.PP) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GE Healthcare AS, Norway | ||||||||||
| Therapeutic Class: | 48 - DIAGNOSTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous and intraarterial use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 05.03.1996 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_VISIPAQUE_05.2022.pdf
|
| SPC: |
SPC_VISIPAQUE_05.2022.pdf
|
| Safety feature | No |
| Data update: | 06.05.2022 |
